Novosound Inks New Transatlantic Partnership

Good news coming from our Glasgow-based portfolio company, Novosound which is expanding its healthcare operations in the US!

Novosound has entered into a partnership with leading US cardiovascular surgeon Todd Rosengart to develop a wearable ultrasound. Talking about the collaboration, Rosengart said: “I have been very impressed with the Novosound technology and how we are applying it to a global clinical need, which we believe will save lives and could indeed become the next vital sign monitor.”

Par Equity first backed Novosound when it was spun out of the University of the West of Scotland in 2018.  The business has since made excellent strides in its technological development and innovation for wireless ultrasounds, raising a total of £10m to date. 

https://bit.ly/47FKJKR